| BIONTECH SE SPON. ADRS 1 |
| USA |
| Gesundheit |
| US09075V1026 / A2PSR2 |
| 22UA (Frankfurt) / BNTX (NASDAQ) |
| FRA:22UA, ETR:22UA, 22UA:GR, NASDAQ:BNTX |
| - |
| https://biontech.de/ |
|
BioNTech SE is a German multinational biotechnology company headquartered in Mainz, specializing in the development of immunotherapies and vaccines for cancer and infectious diseases. Founded in 2008 ..
>Volltext.. |
| 22289.91 Mio. EUR |
| 7968.34 Mio. EUR |
| 3046.59 Mio. EUR |
| 162.53 Mio. EUR |
| -545.55 Mio. EUR |
| -2.27 EUR |
| 248.69 Mio. EUR |
| 10228.22 Mio. EUR |
| -289.9 Mio. EUR |
| 6.47 |
| 7.05% |
| -26.07% |
| - |
| - |
| - |
| 02.06.22 - 1.8290012€ |
| - |
| BIONTECH |
| 04.03.26 |
|
||||
|